About Igentify
Igentify is a company based in Ramat Yishai (Israel) founded in 2016. Igentify has raised $10.5 million across 2 funding rounds from investors including European Union and aMoon. Igentify offers products and services including Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™. Igentify operates in a competitive market with competitors including Zocdoc, Doctolib, Everlywell, Viome and Color, among others.
- Headquarter Ramat Yishai, Israel
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website igentify.com
- Social LinkedIn X Facebook
- Legal Name Igentify Ltd.
- Total Equity Funding$10.5M (USD)
in 2 rounds
- Latest Funding Round$10.5M (USD), Series A
Sep 2019
- InvestorsEuropean Union
& 1 more
Products & Services of Igentify
Igentify offers a comprehensive portfolio of products and services, including Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™.
Provides secure access to genetic information for users.
Analyzes genetic data to support healthcare decisions.
Offers interpretations of genetic information for providers.
Guides the use of genetic data in clinical applications.
Funding Insights of Igentify
Igentify has successfully raised a total of $10.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10.5 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.5M
- Total Rounds 2
- Last Round Series A — $10.5M
- First Round $55,392
(Aug 2019)
- Investors Count 2
All 2 funding rounds of Igentify with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $10.5M | Series A | – | aMoon | – |
| Aug 2019 | $55,392 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Igentify
Igentify has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and aMoon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments in healthcare are focused on by aMoon. | – | amoon.fund | - | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Igentify
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Igentify
29 people are tracked at Igentify (12 in leadership, 13 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Doron M. Behar | Co-Founder & CEO | Leadership |
Udi Zwilinsky | VP R&d At Igentify | Leadership |
Doron Ben-Moshe | Head Of Artificial Intelligence | Leadership |
Bari Adler | Vice President Of Global Sales | Leadership |
Galit Delmar | Co-Founder & VP, Customer Experience | Leadership |
Sharon Topolski-Nahmias | COO | Leadership |
Elliott Greenspan | Co-Founder & Chief Innovation Officer | Leadership |
Dudi Kruh | VP, Product | Leadership |
Rotem Snir | Director of Customer Support | Leadership |
Ofir Amzaleg | Chief Product Officer | Leadership |
Zohar Sherman | VP, Solution Design | Leadership |
Rama Dovrat | VP, HR | Leadership |
Bonnie Federman | Board Member | Board & advisors |
Hagit Baris Feldman | Board Member | Board & advisors |
Kalisi Logan | Board Member | Board & advisors |
Sally Rodríguez | Board Member | Board & advisors |
Eitan Friedman | Board Member | Board & advisors |
Marc Grodman | Board Member | Board & advisors |
Charlie Federman | Board Member | Board & advisors |
Allen Kamer | Board Member | Board & advisors |
9 more people are available in the full profile.
Complete people profiles for Igentify
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Igentify
3 dated milestones of Igentify across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Igentify is founded.
- Funding First funding round of $55K.
- Funding Latest funding round, Series A, of $10.5M.
Competitors of Igentify
Igentify operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zocdoc, Doctolib, Everlywell, Viome and Color, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zocdoc.com | 2007 | New York, United States | $375.97M | 564 | Healthcare appointments are booked online via Zocdoc's platform. | |
| doctolib.fr | 2013 | Levallois Perret, France | $866.43M | – | Doctor appointments are booked via an online platform. | |
| everlywell.com | 2014 | Austin, United States | $330M | 614 | At-home health tests for biomarkers, nutrition, and hormone analysis. | |
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| color.com | 2013 | Burlingame, United States | $506.44M | 687 | Cancer care is delivered through a virtual clinic by Color. | |
| lumahealth.io | 2012 | San Francisco, United States | $152.33M | 68 | Unfilled appointments are managed for healthcare providers through web-based tools. | |
| invitae.com | 2010 | San Francisco, United States | $189.56M | 1,700 | Home-based genetic tests for detecting diseases are provided to individuals. | |
| counsyl.com | 2007 | San Francisco, United States | $112.89M | 503 | DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening | |
| variantbio.com | 2018 | Brooklyn, United States | $127.74M | – | Personalized therapeutics are developed using genomic data for rare diseases. | |
| geneplanet.com | 2008 | Ljubljana, Slovenia | $34.02M | – | DNA-based personalized health and fitness recommendations are offered. |
Detailed competitors of Igentify
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Igentify
The website of Igentify (igentify.com) receives about 10K visits a month.
- Monthly visits10K
▲ 95.8% vs previous month
Latest news on Igentify
Complete news archive for Igentify
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Igentify
10 companies that operate in the same segment as Igentify (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Igentify
Igentify was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Igentify is headquartered in Ramat Yishai, Israel. It is registered at Ramat Yishai, Northern District, Israel.
Igentify is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Grant of $55.39K, raised on Aug 2019.
Igentify was founded in 2016 in Ramat Yishai, Israel, as a biomedical informatics company focused on preventative healthcare. Genomic products and services are offered, including electronic documentation, e-consenting forms, and educational clips for patients. The FamilyFirst test, an expanded carrier screening adapted for the Israeli population, is available through authorized clinics. Over 850 mutations and 260 hereditary diseases are screened using cheek lining DNA samples to support pregnancy planning.
Igentify's top competitors include Zocdoc, Doctolib and Luma Health.
Igentify offers Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™.
Igentify has 2 investors. Key investors include European Union, and aMoon.
Igentify operates through Igentify Ltd..